Literature DB >> 1872338

Acute myocardial infarction associated with prostaglandin E2.

W J Meyer1, S L Benton, T J Hoon, D W Gauthier, V E Whiteman.   

Abstract

Prostaglandin E2 is rarely associated with serious maternal side effects when used for second-trimester pregnancy termination. Acute myocardial infarction complicating therapeutic pregnancy termination with prostaglandin E2 in a patient with chronic glomerulosclerosis and severe hypertension is reported.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1872338     DOI： 10.1016/0002-9378(91)90092-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  3 in total

Review 1.  A risk-benefit assessment of oxytocics in obstetric practice.

Authors:  M Winkler; W Rath
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

2.  Attenuation of ischemic liver injury by prostaglandin E1 analogue, misoprostol, and prostaglandin I2 analogue, OP-41483.

Authors:  E Totsuka; S Todo; Y Zhu; N Ishizaki; Y Kawashima; M B Jin; A Urakami; T Shimamura; T E Starzl
Journal:  J Am Coll Surg       Date:  1998-09       Impact factor: 6.113

3.  Postpartum coronary vasospasm with literature review.

Authors:  Jayanth Koneru; Matthew Cholankeril; Kunal Patel; Fadi Alattar; Ashraf Alqaqa; Hirtaj Virk; Fayez Shamoon; Mahesh Bikkina
Journal:  Case Rep Cardiol       Date:  2014-07-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.